Second-generation device more effective in capturing circulating tumour cells

A redesigned version of the CTC-Chip - a microchip-based device for capturing rare circulating tumour cells (CTCs) - appears to be more effective and should be easier to manufacture than the original. Called the HB-(herringbone) Chip, the new device also may provide more comprehensive and easily accessible data from captured tumour cells. Massachusetts General Hospital (MGH) researchers - including members of the team that developed the CTC-Chip - report the second-generation device in a Proceedings of the National Academy of Sciences paper that has been released online...

Read the whole article on

More from